ASweetLife Team, Author at ASweetLife

Diagnosing Diabetes: A Danish Study on HbA1c Levels and Ethnicity

Until this year, the glycated hemoglobin or hemoglobin A1c (HbA1c) test was used only for monitoring patients once they had been diagnosed with diabetes. In January 2010, however, the American Diabetes Association Standards of Medical Care in Diabetes added the measure of HbA1c 6.5% as a criterion for the diagnosis of diabetes, in addition to the fasting glucose test...

Breastfeeding Reduces Risk of Type 2 Diabetes in Mothers

A new study by University of Pittsburgh researchers has found that women who exclusively breastfeed their children for at least one month are less likely to develop type 2 diabetes. The researchers studied the records of 2233 women, including 1828 mothers of which 56% breastfed their children for at least one month...

Diabetes Pioneer Dies at 96

Dr. William R. Kirtley, a medical researcher pioneer who helped develop drugs after World War II that greatly improved the lives of diabetics, has died at the age of 96. Kirtley was part of a research team at Eli Lilly & Company in Indianapolis that conducted groundbreaking research on diabetes drugs after the war...

Novo Nordisk GlucaGen Hypokit Being Recalled in Canada

Health Canada is informing Canadians that Novo Nordisk Canada Inc. has agreed to voluntarily recall two lots (YW60335 and YW60351) of their product, GlucaGen Hypokit (DIN 02333627) currently available on the Canadian market...

Novo Nordisk Creates “App” to Help Doctors Dose Insulin

Novo Nordisk announced today the availability of NovoDoseTM – the first-ever mobile insulin dosing guide for physicians to look up dosing guidelines and blood glucose goals for their patients with diabetes, a disease that affects nearly 24 million Americans. The guide is available as an application on iTunes and is specific to Novo Nordisk’s modern insulin analog portfolio...

Actos as Dangerous as Avandia, New Study Shows

The continuing controversy surrounding the cardiovascular risk of GlaxoSmithKline's diabetes drug Avandia has led to sharp declines in its use and a surge in sales of the competing drug, Actos. Although the drugs are similar and both had FDA warnings in 2007, Takeda's Actos has been...

Fight Diabetes and Obesity With Asparagus, Artichokes, and Garlic

Raise up your asparagus spear and fight! Diabetes UK is funding research into foods such as garlic, chicory, asparagus and artichokes, according to a report in Telegraph. These foods, known as fermentable carbohydrates, are thought to activate the release of gut hormones that reduce appetite. It is believed such fermentable carbohydrates also enhance sensitivity to insulin, potentially leading to better glucose control.

Go For Green

Leafy green vegetables are low in fat, high in dietary fiber, and rich in folic acid, vitamin C, potassium and magnesium. They also contain phytochemicals, such as lutein and beta-carotene. And a new study shows that eating green leafy vegetables may reduce risk of type 2 diabetes.

Novo Nordisk Spends $375k Lobbying US Government

Danish drugmaker Novo Nordisk, the world's top producer of insulin, spent $375,000 lobbying the U.S. government in the second quarter of 2010 on several diabetes-related issues, among other topics, according to a Bloomberg report

Eating Green Leafy Vegetables Reduces Risk of Type 2 Diabetes

Eating green leafy vegetables may reduce risk of type 2 diabetes, a new study shows. According to the study published in the British Medical Journal, increasing daily consumption of green leafy vegetablescould significantly reduce the risk of type 2 diabetes...